The study’s cross-validation confirmed that ccRCC patients have elevated concentrations of both CD4+ and CD8+ T cells, contrasted with lower levels of monocyte/macrophage cells, as detailed in (Figure 4B). This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.